We will contact you as soon as possible
Hotline: 84-24-39717710
JEVAX®
JAPANESE ENCEPHALITIS VACCINE
JEVAX is a result of technology transfer from the BIKEN Institute, Osaka University, Japan. It is an inactivated purified vaccine derived from mouse-brain tissue infected with the Japanese encephalitis virus (Nakayama strain). The vaccine production involves harvesting mouse brains before the onset of encephalitis symptoms, triturating them in a buffered solution, and then centrifuging the mixture. The obtained supernatants are treated with protamine sulfate, formaldehyde-inactivated, and purified through ultracentrifugation.
Vaccine information
Description
Japanese Encephalitis vaccine (JEVAX®) in Company for Vaccine and Biological production No.1 (VABIOTECH), which has been manufactured under the transferred technology from BIKEN Institute, Osaka University, Japan. This vaccine is used for prophylaxis of Japanese Encephalitis disease.
Japanese Encephalitis vaccine was derived from mouse brain infected with Japanese Encephalitis virus-Nakayama strain. The virus suspension was treated with protamin sulfate, inactivated by formaldehyde, concentrated by ultrafiltered and then purified by ultracentrifugation. TCM-199 was diluent in formulation and thimerosal (max. 0.012% w/v) as preservative. The vaccine is transparent, colourless. Stored at 2 – 8ºC.
COMPOSITION
1 ml contains:
Inactivated, purified Japanese Encephalitis virus……………………….. q.s 1 dose
Thimerosal……………………………………………………………………………………………. ≤ 0.012 %
TCM- 199 w/o red phenol……………………………………………………………….……… q.s 1ml
INDICATION
For prophylaxis of Japanese Encephalitis for adults and children from enough twelve- month old.
CONTRA-INDICATIONS
- Do not use in person with hypersensitivity to any component of JEVAX®
- Congenital diseases.
- Tiredness, fever or intensive infectious diseases.
- Cardiovascular diseases, renal diseases or hepatic diseases.
- Diabetes or malnutrition.
- Leukemia and other malignant diseases
- Anaphylactoid reaction
- Pregnancy.
ADVERSE REACTIONS
- The local adverse effects occur in different level such as: local redness, local swelling ect…
- The systemic adverse effects rarely occur such as: chills, headache, fever ect…
If any of the adverse reactions get serious, or if you notice any adverse reactions not listed in this leaflet, please tell your doctor or pharmatist.
CAUTIONS AND WARNINGS
Cautions
- As a injectable vaccine, always must have epinephrine to use for the case of rare anaphylactic shock may occur.
For pregnant women and breast-feeding women
- With womenduringlactation, notanydataonJapaneseencephalitisvaccinefor these womenduring Therefore, ít should consider thebenefits ofthe vaccineindicated.
Warnings
- All preparation and injection must be sterilized. Remove the flip-off (do not open the rubber stopper), sterilized by alcohol-iodine. Syringe and needle must be sterilized and disposable. Shake well before use. The opened vial of vaccine must be used within 6 hours in 2- 8°C storage condition.
- Person with good immune status repeat 1 dose before a Japanese Encephalitis epidemic.
- In epidemic areas, repeat 1 dose every 3 years to maintain effective immune status.
- Sterilized syringe and needle must be use individually to prevent from HBsAg, HCV, HIV infection….
DOSAGE, ADMINISTRATION
Administration: Inject subcutaneously.
Dosage
From ≥12 months old to ≤ 36 months old (≤ 3 years old)……………………………….. 0.5 ml/dose.
From > 36 months old (3 years old) and adults …………..…………………………………….1.0 ml/dose.
Immunization Schedule:
- Primary immunization: Initial dose
- 2nd dose: one dose after 1st dose one – two weeks.
- 3rd dose: one dose after 1st dose one year.
- Booster immunization: 01 dose subcutaneous injection every 3 years.
DRUG INTERACTIONS
There are not any reports about affecting of JEVAX with other vaccines.
OVERDOSE AND SOLVENT
Overdose study is unfeasible. Up to now, no overdose case report has received from user. Further more JEVAX® is inactivated purified vaccine so it is quite safety. However, as other vaccines, do not overdose.
STORAGE
- Transport and store at from +2ºC to +8ºC.
- Avoid direct sunlight.
- Do not freeze.
SHELF LIFE
The expiry is 24 months from manufacturing date at +2oC to +8oC.
PACKING SIZE
- 5 ml (5 doses) /vial x 10 vials/box.
- 1 ml (1 dose) /vial x 10 vials/box.
SPECIFICATION
Manufacturer
NOTICE
- SHAKE WELL BEFORE USE
- KEEP OUT OF REACH OF CHILDREN.
- READ THE LEAFLET CAREFULLY BEFORE USE
*** All complaints about this vaccine must be reported directly, with information about series number, expiration date and relevant evidence (if any) to the manufacturer: Company for Vaccines and Biological Production No.1 (VABIOTECH). Address: No. 1 Yersin, Pham Đinh Ho Ward, Hai Ba Trung District, Hanoi. Phone: +84-24-39717710
Related products
MANUFACTURED PRODUCTS
HAVAX®Hepatitis A Vaccine
MANUFACTURED PRODUCTS
Gene-HBvaxRecombinant hepatitis B vaccine
MANUFACTURED PRODUCTS